In addition, inactivation of the A isoform of RASSF2 by promoter methylation has been found to correlate with a higher frequency of lymph node metastases in patients with nasopharyngeal carcinoma [26]. The gene discussed is RASSF2; the disease is nasopharyngeal carcinoma.